Telemedicine
WeChat monitoring of home COVID patients
Open access · cc by · source: Europe PMC
WeChat-based telemedicine monitored 74 home-quarantined COVID-19 patients; 8% needed admission and all recovered.
Study at a glance
- Design
- Other — WeChat telemedicine monitoring programme for home-quarantined COVID-19 patients (not randomised)
- N
- N=74 · 6 (8%) hospitalised after detected deterioration; all 74 recovered
- Population
- Home-quarantined patients with COVID-19
- Outcome
- Detection of deterioration requiring hospital admission
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Among 74 patients, 6 (8%) were hospitalised after detected deterioration; all 74 recovered.
Methodology
Investigators used a WeChat telemedicine system with structured symptom assessment to monitor home-quarantined COVID-19 patients and escalate care when deterioration was detected.
Limitations
Small single-system retrospective series without a concurrent control group cannot prove telemedicine caused recovery.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Multiple studies in this library examine telemedicine with empirical patient or population outcomes rather than opinion alone.
Evidence for the claim as stated.
Among 74 patients, 6 (8%) were hospitalised after detected deterioration; all 74 recovered.
Evidence for the claim as stated.
Effect sizes and settings differ across telemedicine studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Evidence for the claim as stated.
Not every paper tagged 'cohort' is a large incidence study. A WeChat telemedicine series of 74 home-quarantined COVID-19 patients hospitalised 6 people (8%) after detected deterioration; all 74 recovered. That is a small retrospective care series without a concurrent control, not a prospective exposure–disease cohort like 45 and Up or the diet-depression follow-up.
Evidence for the claim as stated.
Follow-up of thousands of event-free adults is a different design from a 74-person telemedicine case series, even if both get filed as cohorts. The HLI, diet-depression, smoking-CVD and Rotterdam papers estimate rates or attributable fractions over years. The WeChat paper describes outcomes after care already delivered, with no control group, so it cannot show that monitoring caused recovery.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Effect sizes and settings differ across telemedicine studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
- Supports · Dementia-carer internet support forum
- Supports · How did rural telemedicine change in COVID?
Follow-up of thousands of event-free adults is a different design from a 74-person telemedicine case series, even if both get filed as cohorts. The HLI, diet-depression, smoking-CVD and Rotterdam papers estimate rates or attributable fractions over years. The WeChat paper describes outcomes after care already delivered, with no control group, so it cannot show that monitoring caused recovery.
Related papers in this topic
Same topic cluster — not a recommendation engine.